Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression
Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression
OBJECTIVES: To compare the magnitude of cognitive impairment against age-expected levels across the immune mediated inflammatory diseases (IMIDs: systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], axial spondyloarthritis [axSpA], psoriatic arthritis [PsA], psoriasis [PsO]).
METHODS: A pre-defined search strategy was implemented in Medline, Embase and Psychinfo on 29/05/2021. Inclusion criteria were: (i) observational studies of an IMID, (ii) healthy control comparison, (iii) measuring cognitive ability (overall, memory, complex attention/executive function, language/verbal fluency), and (iv) sufficient data for meta-analysis. Standardised mean differences (SMD) in cognitive assessments between IMIDs and controls were pooled using random-effects meta-analysis. IMIDs were compared using meta-regression.
RESULTS: In total, 65 IMID groups were included (SLE: 39, RA: 19, axSpA: 1, PsA: 2 PsO: 4), comprising 3141 people with IMIDs and 9333 controls. People with IMIDs had impairments in overall cognition (SMD: -0.57 [95% CI -0.70, -0.43]), complex attention/executive function (SMD -0.57 [95% CI -0.69, -0.44]), memory (SMD -0.55 [95% CI -0.68, -0.43]) and language/verbal fluency (SMD -0.51 [95% CI -0.68, -0.34]). People with RA and people with SLE had similar magnitudes of cognitive impairment in relation to age-expected levels. People with neuropsychiatric SLE had larger impairment in overall cognition compared with RA.
CONCLUSIONS: People with IMIDs have moderate impairments across a range of cognitive domains. People with RA and SLE have similar magnitudes of impairment against their respective age-expected levels, calling for greater recognition of cognitive impairment in both conditions. To further understand cognition in the IMIDs, more large-scale, longitudinal studies are needed.
Humans, Arthritis, Psoriatic/complications, Arthritis, Rheumatoid/complications, Cognition, Cognitive Dysfunction/etiology, Lupus Erythematosus, Systemic/complications, Psoriasis, Axial Spondyloarthritis/complications, Arthritis/complications, Inflammation/complications
152131
Gwinnutt, James M
a3eb718a-3353-42ca-822b-44cb2d72eb07
Toyoda, Task
53e5d636-bdba-4146-b6ff-aaeb54c9bb02
Barraclough, Michelle
39628e59-1de2-453c-b726-aa246a654658
Verstappen, Suzanne M M
34d9aaa3-c50d-4a7f-8d81-b3d61e66f393
Hornberger, Michael
a48c1c63-422a-4c11-9a51-c7be0aa3026d
MacGregor, Alex
6a6eb75d-fde6-48dd-82b4-fc7b8a747c1b
15 December 2022
Gwinnutt, James M
a3eb718a-3353-42ca-822b-44cb2d72eb07
Toyoda, Task
53e5d636-bdba-4146-b6ff-aaeb54c9bb02
Barraclough, Michelle
39628e59-1de2-453c-b726-aa246a654658
Verstappen, Suzanne M M
34d9aaa3-c50d-4a7f-8d81-b3d61e66f393
Hornberger, Michael
a48c1c63-422a-4c11-9a51-c7be0aa3026d
MacGregor, Alex
6a6eb75d-fde6-48dd-82b4-fc7b8a747c1b
Gwinnutt, James M, Toyoda, Task, Barraclough, Michelle, Verstappen, Suzanne M M, Hornberger, Michael and MacGregor, Alex
(2022)
Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression.
Seminars in Arthritis and Rheumatism, 58, .
(doi:10.1016/j.semarthrit.2022.152131).
Abstract
OBJECTIVES: To compare the magnitude of cognitive impairment against age-expected levels across the immune mediated inflammatory diseases (IMIDs: systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], axial spondyloarthritis [axSpA], psoriatic arthritis [PsA], psoriasis [PsO]).
METHODS: A pre-defined search strategy was implemented in Medline, Embase and Psychinfo on 29/05/2021. Inclusion criteria were: (i) observational studies of an IMID, (ii) healthy control comparison, (iii) measuring cognitive ability (overall, memory, complex attention/executive function, language/verbal fluency), and (iv) sufficient data for meta-analysis. Standardised mean differences (SMD) in cognitive assessments between IMIDs and controls were pooled using random-effects meta-analysis. IMIDs were compared using meta-regression.
RESULTS: In total, 65 IMID groups were included (SLE: 39, RA: 19, axSpA: 1, PsA: 2 PsO: 4), comprising 3141 people with IMIDs and 9333 controls. People with IMIDs had impairments in overall cognition (SMD: -0.57 [95% CI -0.70, -0.43]), complex attention/executive function (SMD -0.57 [95% CI -0.69, -0.44]), memory (SMD -0.55 [95% CI -0.68, -0.43]) and language/verbal fluency (SMD -0.51 [95% CI -0.68, -0.34]). People with RA and people with SLE had similar magnitudes of cognitive impairment in relation to age-expected levels. People with neuropsychiatric SLE had larger impairment in overall cognition compared with RA.
CONCLUSIONS: People with IMIDs have moderate impairments across a range of cognitive domains. People with RA and SLE have similar magnitudes of impairment against their respective age-expected levels, calling for greater recognition of cognitive impairment in both conditions. To further understand cognition in the IMIDs, more large-scale, longitudinal studies are needed.
This record has no associated files available for download.
More information
Published date: 15 December 2022
Additional Information:
Copyright © 2022. Published by Elsevier Inc.
Keywords:
Humans, Arthritis, Psoriatic/complications, Arthritis, Rheumatoid/complications, Cognition, Cognitive Dysfunction/etiology, Lupus Erythematosus, Systemic/complications, Psoriasis, Axial Spondyloarthritis/complications, Arthritis/complications, Inflammation/complications
Identifiers
Local EPrints ID: 505235
URI: http://eprints.soton.ac.uk/id/eprint/505235
ISSN: 0049-0172
PURE UUID: efa86b3b-2350-415b-8c28-e3bf2bd8457c
Catalogue record
Date deposited: 02 Oct 2025 16:49
Last modified: 03 Oct 2025 02:18
Export record
Altmetrics
Contributors
Author:
James M Gwinnutt
Author:
Task Toyoda
Author:
Michelle Barraclough
Author:
Suzanne M M Verstappen
Author:
Michael Hornberger
Author:
Alex MacGregor
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics